Envista Holdings Co. (NYSE:NVST – Free Report) – Equities research analysts at William Blair cut their Q4 2024 earnings per share estimates for shares of Envista in a report released on Thursday, October 31st. William Blair analyst B. Vazquez now anticipates that the company will post earnings per share of $0.27 for the quarter, down from their prior estimate of $0.29. The consensus estimate for Envista’s current full-year earnings is $0.69 per share. William Blair also issued estimates for Envista’s Q1 2026 earnings at $0.32 EPS, Q2 2026 earnings at $0.34 EPS and Q3 2026 earnings at $0.33 EPS.
Envista (NYSE:NVST – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. Envista had a positive return on equity of 3.59% and a negative net margin of 53.42%. The company had revenue of $601.00 million for the quarter, compared to analysts’ expectations of $590.34 million. During the same period last year, the firm earned $0.43 EPS. Envista’s revenue for the quarter was down 4.8% compared to the same quarter last year.
Read Our Latest Stock Report on Envista
Envista Trading Down 0.1 %
Shares of NVST stock opened at $20.94 on Friday. Envista has a 52-week low of $15.15 and a 52-week high of $25.64. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.90 and a current ratio of 2.22. The firm has a market capitalization of $3.60 billion, a PE ratio of -2.69 and a beta of 1.32. The stock has a fifty day simple moving average of $18.64 and a two-hundred day simple moving average of $18.08.
Insiders Place Their Bets
In related news, CFO Eric D. Hammes purchased 24,532 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was purchased at an average price of $16.33 per share, with a total value of $400,607.56. Following the completion of the purchase, the chief financial officer now owns 24,532 shares of the company’s stock, valued at approximately $400,607.56. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is owned by insiders.
Institutional Trading of Envista
Institutional investors and hedge funds have recently modified their holdings of the stock. State of Michigan Retirement System raised its stake in Envista by 2.4% in the first quarter. State of Michigan Retirement System now owns 42,163 shares of the company’s stock worth $901,000 after buying an additional 1,000 shares in the last quarter. Capstone Investment Advisors LLC grew its holdings in Envista by 51.3% in the first quarter. Capstone Investment Advisors LLC now owns 64,779 shares of the company’s stock worth $1,385,000 after purchasing an additional 21,950 shares during the last quarter. FORA Capital LLC grew its holdings in Envista by 11.1% in the first quarter. FORA Capital LLC now owns 52,198 shares of the company’s stock worth $1,116,000 after purchasing an additional 5,205 shares during the last quarter. Mutual of America Capital Management LLC grew its holdings in Envista by 1.0% in the first quarter. Mutual of America Capital Management LLC now owns 196,022 shares of the company’s stock worth $4,191,000 after purchasing an additional 1,967 shares during the last quarter. Finally, Central Pacific Bank Trust Division purchased a new position in Envista in the first quarter worth $479,000.
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
See Also
- Five stocks we like better than Envista
- 3 Tickers Leading a Meme Stock Revival
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What Are Dividend Champions? How to Invest in the Champions
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.